Home
Eric Venker, President & Immunovant CEO: Roivant Sciences ROIV Sell · Filed 25/09/23
Trade details
- Type
- Insider sale
- Amount
- $10,223,079.1
- Shares · price
- 683,818 sh · $14.95 a share
- Held after
- 1,969,767 sh
- Trade date
- 25/09/19
- Filed
- 25/09/23
- Days to filing
- 4 days
Sold 25.8% of holdings
- Share of holding sold
- 25.8%
Roivant Sciences trades, last 26 weeks
What else happened in Roivant Sciences around then
Filed or reported within 30 days of the trade day · 25/08/20~25/10/19Eric Venker's recent trades
- Eric Venker
Planned sale10b5-1 planRoivant Sciences
Planned sale10b5-1 planRoivant Sciences
ROIV
$7.3M
200,000 sh
$7.3M
Filed 09/30
Traded 09/30
- Eric Venker
Planned sale10b5-1 planRoivant Sciences
Planned sale10b5-1 planRoivant Sciences
ROIV
$7.1M
200,000 sh
$7.1M
Filed 08/28
Traded 08/28
- Eric Venker
Planned sale10b5-1 planRoivant Sciences
Planned sale10b5-1 planRoivant Sciences
ROIV
$7M
200,000 sh
$7M
Filed 07/27
Traded 07/27
- Eric Venker
Sell10b5-1 planRoivant Sciences
Sell10b5-1 planRoivant Sciences
ROIV
$5.1M
153,766 sh
$5.1M
Filed 06/26
Traded 06/24
- Eric Venker
Sell10b5-1 planRoivant Sciences
Sell10b5-1 planRoivant Sciences
ROIV
$1.5M
46,234 sh
$1.5M
Filed 06/26
Traded 06/24